Arteris Q1 2026 Earnings Call - Record Revenue and Raised Guidance on AI Chip Demand
Summary
Arteris delivered a record-breaking first quarter in 2026, with revenue climbing 39% year-over-year to $22.9 million and trailing twelve-month royalties surging 67% to $9.9 million. The company’s strategic pivot toward AI-driven semiconductor design, particularly in enterprise computing and high-bandwidth memory, has fundamentally shifted its revenue mix. Enterprise computing now leads licensing activity, surpassing traditional automotive dominance, while aerospace and defense emerges as a fast-growing vertical following the Cycuity acquisition. Management raised full-year guidance, citing a robust pipeline and accelerating deal flow, with non-GAAP profitability expected by year-end.
The call highlighted a structural shift in Arteris’ business model: from a niche semiconductor IP provider to a critical enabler of AI infrastructure. With two-thirds of customer engagements now tied to AI chips, the company is capitalizing on the complexity and security demands of next-generation data center and edge devices. The retirement of CFO Nick Hawkins marks the end of an era, but his successor inherits a debt-free balance sheet, positive free cash flow, and a clear path to profitability. As Arteris navigates this inflection point, the market is watching closely to see if its AI tailwinds can sustain momentum beyond the current cycle.
Key Takeaways
- Record revenue of $22.9 million, up 39% year-over-year, beating the top end of guidance.
- Trailing twelve-month royalties surged 67% to $9.9 million, driven by AI chip demand and higher-priced semiconductor nodes.
- Annual contract value plus royalties reached a record $92.8 million, up 39% year-over-year.
- Remaining performance obligations (RPO) hit $118 million, up 33% year-over-year, with just over half expected to be recognized in the next 12 months.
- Enterprise computing (data center, HPC, HBM) is now the largest vertical for licensing, surpassing automotive, which historically dominated.
- Two-thirds of customer engagements are now tied to AI chips, reflecting a structural shift in Arteris’ revenue mix.
- Management raised full-year 2026 guidance: revenue to $91-$95 million (up $2M) and ACV plus royalties to $102-$106 million (up $2M).
- Non-GAAP profitability expected by Q4 2026, with non-GAAP operating loss narrowed to $4.5-$8.5 million for the full year.
- Cycuity acquisition is showing promise, with government orders closed and early commercial deals emerging, contributing to aerospace and defense’s rise to ~10% of ACV.
- CFO Nick Hawkins retiring August 31, 2026, leaving a debt-free balance sheet, $41.9 million in cash, and positive free cash flow.
Full Transcript
Operator: Good afternoon, everyone, and welcome to the Arteris first quarter 2026 earnings call. Please note that this call is being recorded and simultaneously webcast. All material contained in the webcast is the sole property and copyright of Arteris with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion at Sapphire Investor Relations. Please go ahead.
Erica Mannion, Investor Relations, Sapphire Investor Relations: Thank you and good afternoon. With me today from Arteris are K. Charles Janac, Chief Executive Officer, and Nick Hawkins, Chief Financial Officer. Charlie will begin with a brief review of the business results for the first quarter ended March 31, 2026. Nick will review the financial results for the first quarter of 2026, followed by the company’s outlook for the second quarter and the full year of 2026. We will open the call for questions. Before we begin, I’d like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements are based on management’s current expectations and assumptions and involve material risks and uncertainties that could cause actual results and events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.
Additional information regarding these risks, uncertainties, and factors that could cause results to differ appear in the press release Arteris issued today and in the documents and reports filed by Arteris from time to time with the Securities and Exchange Commission. Please note, during this call, we will cite certain non-GAAP measures, including, among others, non-GAAP net loss, non-GAAP net loss per share, and free cash flow, which are not measures prepared in accordance with the U.S. GAAP. The non-GAAP measures are presented as we believe that they provide investors with a means of evaluating and understanding how the company’s management evaluates the company’s operating performance. These non-GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with U.S. GAAP.
A reconciliation of these non-GAAP measures to the nearest GAAP measure can be found in the press release for the quarter ended March 31, 2026. In addition, for a definition of certain of the key performance indicators used in this presentation, such as annual contract value and remaining performance obligations, please see the press release for the quarter ended March 31, 2026. These key performance indicators are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may differ from similarly titled metrics or measures used by other companies, securities analysts, or investors. Listeners who do not have a copy of the press release for the quarter ended March 31, 2026 may obtain a copy by visiting the investor relations section of the company’s website.
In addition, management will be referring to the first quarter 2026 earnings presentation, which can be found in the investor relations section of the company’s website under Events and Presentations tab. Now I will turn the call over to Charlie.
K. Charles Janac, Chief Executive Officer, Arteris: Thank you, Erica, and thanks to everyone for joining us on our call today. The first quarter of 2026 was a robust quarter for Arteris as we reached another record annual contract value plus royalties of $92.8 million, representing a 39% year-on-year increase. We also achieved record revenue, record royalties, and record revenue backlog. Customer engagement in the quarter included both existing customer renewals as well as adding new logos. We won license deals in enterprise computing, automotive communications, consumer electronics, and aerospace and defense sectors. AI integration into all types of electronics from data centers to edge devices and physical AI systems is increasing the demand for advanced connectivity and security products, and now two-thirds of our customer engagements are into AI chips. New chips and chiplets continue to get more complex and perform more advanced computing.
Efficient, safe, and secure data movement within those devices is essential, which is driving the growing adoption of Arteris products and solutions. Every semiconductor must move data to be a chip or chiplet. Rapidly advancing data movement powered by chips is evident in recent earnings releases by semiconductor companies. Many of these companies are also Arteris customers and have both beaten their first quarter revenue projections and raised guidance for the year. This performance has clearly flowed through into our royalty stream, which has increased 67% year-over-year. Enterprise computing, which includes data centers, High Performance Computing or HPC, including High Bandwidth Memory or HBM, and other AI infrastructure companies, was again the biggest contributor to our licensing activity in the quarter. This includes a leading global hyperscaler, which expanded its use of Arteris’ Network-on-Chip technology for its next generation of data center chips.
Advanced AI data centers are experiencing strong demand for HBM, and I’m pleased to say that another leading global memory supplier is now utilizing Arteris system IP to accelerate their memory chip development. Automotive also continues to be a strong sector for us, where our technology is helping to meet the needs of physical AI systems. An example was an important first quarter deal announcement with Renesas that increased their licenses and deployed our system IP for their most advanced R-Car Gen 5 SoC series. Tailored for advanced driver assistance and automatic driving systems, this latest SoC delivers AI performance of up to 400 trillion operations per second, or TOPS, with multi-die chiplet extensions to boost AI performance using Arteris’ Network-on-Chip technology for silicon data movement.
Communication with efficient, safe, and secure data movement is also playing an increasingly important role in transmitting data, particularly between data centers and edge and endpoint devices. In the first quarter, one of the leading European 5G and 6G communications equipment players further expanded their use of Arteris technology to accelerate the integration of advanced telecommunication chips. Satellites extend communications into aerospace and defense, where the pace of innovation and development of advanced, resilient, safe, and secure semiconductors is growing rapidly. In the first quarter, a leading U.S. space infrastructure company expanded its use of Arteris for the development of next-generation space applications. Beyond Earth’s orbit, it was a pleasure to see the success of the Artemis 2 mission, where AMD chips with built-in Arteris technology were used to support critical sensor fusion, data routing, and image processing for the Orion spacecraft.
This is yet another example of Arteris use in data-intensive space exploration. We continue to see adoption of our FlexGen smart NoC IP at major accounts and startups. We are also working with early adopters on 2 products for optimized chiplet and multi-die system IP, which we anticipate deploying in production during the second half of 2026, with focus on AI, HPC, and ADAS designs. We broadened our system IP portfolio, which addresses key aspects of advanced chip design through the acquisition of Cycuity, a leading chip cybersecurity company. This technology is critical to the security of chips regardless of their complexity. We are starting the process of leveraging our deep relationships with over 200 semiconductor design companies and are already seeing strong interest from many of these customers across many verticals, including data center, aerospace and defense, consumer, automotive, and communications.
By way of example, a top 5 U.S.-based hyperscaler, which is an existing Arteris customer, has licensed Arteris security technology in the 1st quarter to help mitigate cybersecurity risks. The ever-increasing focus on cybersecurity threats is highlighting the need for our solutions, which identify and help mitigate cybersecurity vulnerabilities during chip development phase before silicon mass production. We recently announced a collaboration with MIPS to accelerate the development of physical AI chips. MIPS will use Arteris’ FlexGen smart NoC IP and Magillem SoC integration automation software to help accelerate the development of scalable SoC platforms targeting high-growth markets in physical AI, including automotive microcontroller units, MCUs, and advanced driver assistance systems, ADAS, robotics, and embedded computing. Lastly, Arteris was named to Fast Company’s list of the world’s most innovative companies of 2026.
Arteris ranks number 4 in the most innovative companies in the North America category, as this year’s list shines a spotlight on businesses that are shaping industry through their innovations. Arteris joins the ranks of Google, Nvidia, Anthropic, and more in Fast Company’s 2026 list of world’s most innovative companies. Arteris also won a Stevie Award for 2026 Technology Innovation of the Year in the software category for our Cycuity semiconductor cybersecurity products. On an organizational front, today, we also announced that Nick Hawkins, our CFO, has chosen to retire effective August 31, 2026. Nick will take us through our Q2 report and continue to serve as an advisor to Arteris after his retirement date to facilitate an orderly transition. Nick leaves the company in great shape with no debt, positive free cash flow, and major contributions to three acquisitions.
Nick has been an invaluable partner during a transformative period for Arteris. We thank Nick for his dedication to the company and wish him all the best. With that, I’ll turn it over to Nick to discuss our financial results in more detail.
Nick Hawkins, Chief Financial Officer, Arteris: Thank you, Charlie. Good afternoon, everyone. It has been a rewarding and enjoyable experience to help lead Arteris through an important stage in its development. I am proud of the exceptional finance team we have built and what the company has accomplished. During my seven years at Arteris, in addition to leading the company through its IPO, I’ve also led our M&A processes, including the important recent acquisition of the cybersecurity company, Cycuity. Arteris has grown substantially in revenue and market capitalization, is now cash flow positive, and is transitioning to profitability this year. It has been a privilege to serve under Charlie and our excellent Board, alongside our industry-leading Leadership Team and all our people. Arteris is well positioned for the future, and I look forward to following the company’s continued progress in the years ahead.
As I review our first quarter results for 2026 today, please note I will be referring to GAAP as well as non-GAAP metrics. Please note also that a reconciliation of GAAP to non-GAAP financials is included in today’s earnings release, which is available on our website. Also, as a reminder, I will be referring to the Q1 2026 earnings presentation, which can be found in the investor relations section of the company’s website under the Events and Presentations tab. We had a strong first quarter, beating the top end of our revenue and ACV plus royalties guidance and meeting the top end of our non-GAAP operating income guidance range. Turning to slide 5 of the presentation. Total revenue for the first quarter was $22.9 million, up 39% year-over-year and above the top end of our guidance range.
Notably, training 12-month royalties was $7.9 million, 67% higher year-over-year, setting a new record high. Our royalty stream today is fueled by a balanced mix of customers across all our vertical markets. Our large royalty reporters, which we define as over six-figure dollars per quarter, are in automotive, consumer, enterprise computing, and aerospace and defense. The number of customers reporting a quarter million-plus royalty dollars has grown from 1 a year ago to 3 currently, further highlighting our rapidly diversifying and growing royalty revenue stream. At the end of the first quarter, ACV plus royalties was $92.8 million, up 39% year-over-year, above the top end of our guidance range and at a new record high.
Remaining performance obligations, or RPO, which is our contracted future revenue at the end of the first quarter totaled $118 million, 33% higher year-over-year and another record high for Arteris. We expect just over half of our RPO at the end of the first quarter will be recognized as revenue in the 12 months starting April 1, 2026. Non-GAAP gross profit in the quarter was $20.1 million, representing a gross margin of 87%. GAAP gross profit in the quarter was $19.7 million, representing gross margin of 86%. This now reflects for the first time the inclusion of subcontractor costs as cost of revenue for certain security government contracts. Now moving to slide 6. Non-GAAP operating expense in the quarter is $22.6 million.
In line with our operating leverage goals, we are maintaining our commitment to limit overall growth in OpEx to 50% of our revenue growth. We believe that our investments into product development and customer success will help to accelerate our top line growth in the coming years. At the same time, we are delivering operating leverage, which is being driven across all cost categories, and we remain disciplined in our spending and investments, in particular in G&A spending, which has on average grown at less than 1/4 of the rate of revenue on a non-GAAP basis over the last 3 years. This has resulted in a 31 percentage point improvement in non-GAAP operating margin over that period. Total GAAP operating expense for the first quarter was $29 million, which included acquisition-related expenses of $0.6 million in the first quarter.
non-GAAP operating loss in the quarter was $2.5 million at the top end of our guidance range. GAAP operating loss for the first quarter was $9.3 million compared to a loss of $7.7 million in the prior year period. non-GAAP net loss in the quarter was $1.2 million or diluted net loss per share of $0.03. GAAP net loss in the quarter was $8 million or diluted net loss per share of $0.17. Moving to slide seven and turning to the balance sheet and cash flow. We ended the quarter with $41.9 million in cash equivalents, and investments, and we have no financial debt.
Free cash flow, which includes capital expenditure, was negative $7.4 million in the first quarter, including approximately $3 million deal consideration elements and fees related to the Cycuity acquisition that closed in the quarter. I would now like to turn to our outlook for the second quarter and the full year 2026 and refer now to slide 8. First, starting with the next quarter, we will no longer be guiding quarterly free cash flow. As our average deal size continues to grow, we believe that the consequent fluctuations in quarter-to-quarter operating cash flows make the guidance of this KPI less helpful to investors. Additionally, on an annual basis, we are already free cash flow positive, having delivered that in 2025 and guiding increased positive free cash flow for 2026. This was our first strategic financial objective.
We are now focused on delivering our next strategic financial objective, the inflection to non-GAAP profitability towards the end of the current year. For the second quarter of 2026, we expect ACV plus royalties of $95 million-$99 million, revenue of $23 million-$24 million, non-GAAP operating loss of $3 million-$2 million, free cash flow of positive $2 million to positive $8 million. As we look forward to the full year of 2026, we are seeing continued strength in semiconductors and signs of an upward trend cycle in the market. Consequently, we are raising our guidance for the full year on top and bottom line metrics.
For the full year 2026, our guidance is as follows: ACV plus royalties to exit 2026 at $102 million-$106 million, an increase of $2 million from prior guidance. Revenue of $91 million-$95 million, $2 million higher than prior guidance, and representing a 32% year-over-year increase at the midpoint. Non-GAAP operating loss of between $8.5 million-$4.5 million, an improvement of $0.5 million from prior guidance. Non-GAAP free cash flow of positive $5 million-positive $9 million. We’re seeing a strong start to the second quarter, with momentum and increasing customer engagement leading us to believe that we will see continued strength in the second half of the year.
Building on our strong revenue growth, coupled with carefully focused expense discipline that is delivering operating leverage, we continue to believe that Arteris is on a path to profitability, and we expect to report a non-GAAP operating profit for a period as early as the fourth quarter of the current year. With that, I will turn the call back to the operator for the Q&A portion of the call.
Operator: Thank you. Ladies and gentlemen, we will now begin the question-and-answer session. Should you have a question, please press star followed by the number 1 on your touch tone phone, and you will hear a prompt that your hand has been raised. If you wish to decline from the polling process, please press the star followed by the number 2. We’ll pause for just a moment to compile the Q&A roster. Your first question comes from the line of Kevin Cassidy of Rosenblatt. Please go ahead.
Kevin Cassidy, Analyst, Rosenblatt: Yes, thanks for taking my question, and congratulations on the great results. Nick, congratulations on a successful career, and all the best as you go through the next stage.
Nick Hawkins, Chief Financial Officer, Arteris: Thank you, Kevin.
Kevin Cassidy, Analyst, Rosenblatt: My question Yes. Yeah, on the hyperscaler design win and the, also the high bandwidth memory, what’s the timeline of those products coming to market or generating royalties? I guess I’m trying to get a feel, is there a acceleration in any of these hyperscaler ASICs or any of these development?
Nick Hawkins, Chief Financial Officer, Arteris: Hey.
Kevin Cassidy, Analyst, Rosenblatt: Sorry.
Nick Hawkins, Chief Financial Officer, Arteris: Kevin, this is Nick. Let me handle the royalties part of that question. You know, generally speaking, the design cycles in that space are a little bit quicker than you’d expect in, say, automotive, which is quite a long design cycle, as you know, can be up to 6 years in some cases. In this sphere, it’s more like 2 to 3 years that we’d expect to see something floating through from that.
Kevin Cassidy, Analyst, Rosenblatt: Okay. Same with on the High Bandwidth Memory?
Nick Hawkins, Chief Financial Officer, Arteris: Similar. Yeah.
K. Charles Janac, Chief Executive Officer, Arteris: Yeah. I mean, those are all going into data center AI, those are basically some of the quickest design cycles that we see. Also, the volumes are actually more significant than they used to be in the past. These products have a much faster churn than like Nick said, the automotive, for example. They rise quicker and they also die quicker.
Kevin Cassidy, Analyst, Rosenblatt: Okay. Yeah, that was gonna be my next question is the life cycle of the products as they come to the market. Also, I would imagine as they go down the process to smaller process nodes, the price of the products go up, so your overall royalties could be increasing compared to the past generation.
K. Charles Janac, Chief Executive Officer, Arteris: yeah. I mean.
Nick Hawkins, Chief Financial Officer, Arteris: Yeah, that’s true, Kevin. Sorry, Charlie.
K. Charles Janac, Chief Executive Officer, Arteris: These tend to be high-priced chips.
Kevin Cassidy, Analyst, Rosenblatt: Right. Right. And getting more expensive, those. Yes. Okay, great. Thank you.
Operator: Once again, if you wish to ask a question, please press star one to join the queue. Your next question comes from the line of Joshua Buchalter of TD Cowen. Please go ahead.
Joshua Buchalter, Analyst, TD Cowen: Hey, guys. Thank you for taking my question. Congrats on the results. You know, more importantly, best wishes and a big thank you to Nick on your next endeavor. Yeah, I guess to start maybe big picture, as we think about the raise of the annual guidance, how much of this would you categorize as coming from the better royalty environment that you spoke to just from better chip sell-through versus, you know, increased confidence in licensing deals that are, you know, that you expect to sign over the next several quarters? Thank you.
Nick Hawkins, Chief Financial Officer, Arteris: Let me take that one, Charlie. Josh, thanks for your kind words. It’s been a pleasure, I’ve got to say. On the increased guidance, I’ll say just one general thing, which is, you know, philosophically, we tend to be careful on our guidance. We’re very mindful of guiding our friends on the street diligently. We don’t like to get over our skis on guidance, but we are seeing a very strong trajectory in royalties. The 12 months trailing was up 67%. Actually year-over-year first quarter, interestingly, was up over 100%. We are seeing a nice pick up there, and we’re seeing more people reporting bigger and bigger numbers.
That’s part of it. There is, I would categorize the first quarter as robust and good for a deal flow perspective in dollars. The start to the second quarter was very strong. We actually had the strongest April on record in terms of deal flow by a significant margin. Something like 4 times bigger than the next biggest April we’ve ever seen. We’re seeing a lot of activity. We’re seeing a really strong pipeline on deals. I think that we want to wait until we’re a little further through the quarter to see if this robustness continues and persists before we look at future guidance.
Joshua Buchalter, Analyst, TD Cowen: Okay. Thank you for all the color there. And then maybe following up on some of Kevin’s questions earlier. You know, you’ve been highlighting some pretty sizable hyperscale data center wins, I think with, you know, FlexGen, but other IP over the last few quarters. How should we think about the scale of data center overall compared to your, you know, the historic auto exposure? You know, given it moves faster, as you mentioned in response to Kevin’s, like, what’s a reasonable timeframe at which that could be, you know, a more meaningful portion of overall revenue in the model? Thank you.
K. Charles Janac, Chief Executive Officer, Arteris: Yeah, I mean, the data center segment from a license perspective is growing, you know, very nicely, right? On the royalty side, because data center, though the chips are higher priced, the volumes are lower, you know, we expect automotive to be, you know, continue to be a pretty solid royalty generator. On the license side, we’re definitely seeing solid growth from our data center customers.
Nick Hawkins, Chief Financial Officer, Arteris: If I can add to that also, from a quantitative perspective, Josh, Enterprise is now, which is where our data center business resides, in our verticals, is now the largest of our verticals in terms of license generation. It’s slightly now higher than automotive, which used to be the number 1. They’re both in the sort of 30%-35% range. What’s interesting is aerospace and defense now, partially as a result of the addition of Cycuity, is now close to 10% of our ACV. It’s an interesting developing field.
Joshua Buchalter, Analyst, TD Cowen: Thank you for the color, both.
Operator: Once again, if you wish to ask a question, please press star 1 to join the queue. We have a follow-up question from Kevin Cassidy of Rosenblatt. Please go ahead.
Kevin Cassidy, Analyst, Rosenblatt: Hey. Yeah, thanks for taking my follow-up question. Just on the Cycuity acquisition and now that you’ve had them for a quarter or so, can you say is it coming in better than expected? Yeah, I guess if you could give us a, you know, what’s the pipeline look like from here?
K. Charles Janac, Chief Executive Officer, Arteris: We’ve really started in middle of January, so it’s early days. There were some pretty good government orders in flight, which we closed. That’s very promising. For the second quarter, we’re starting to see some very, very promising deals from the commercial side. We think that this acquisition is gonna turn out just fine. Cybersecurity, because of the Mythos product and other sort of AI-based technologies, the cybersecurity is coming to forefront. We think that all of our customers, of which there’s more than 200, can use the Cycuity product. We’re very excited about the potential, but it looks promising, but it’s relatively early days.
Kevin Cassidy, Analyst, Rosenblatt: Okay. Thank you.
Operator: There are no further questions at this time. I will now turn the call over back to Charlie Janac for closing remarks.
K. Charles Janac, Chief Executive Officer, Arteris: Well, thank you for joining our call today and for your interest in Arteris. We look forward to meeting with you at and updating you on our business progress in the quarters ahead and seeing some of you at some investment conferences. Thank you for your support.
Operator: Ladies and gentlemen, this concludes today’s conference call. Thank you everyone for joining. You may now disconnect.